XML 50 R42.htm IDEA: XBRL DOCUMENT
v3.25.2

Organization and Nature of the Business - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands |  |  |  |  | 1 Months Ended | 6 Months Ended |  |
--- | --- | --- | --- | --- | --- | --- | --- | ---
Jan. 23, 2024 | Jan. 22, 2024 | Aug. 31, 2022 | Mar. 12, 2021 | Jan. 31, 2024 | Nov. 30, 2022 | Jun. 30, 2025 | Jun. 30, 2024 | Apr. 07, 2025 | Dec. 31, 2024
Schedule Of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |
Outstanding warrants, Weighted average exercise price |  | $ 2.3999 |  |  |  |  |  |  |  |
Common stock price per share |  | $ 0.0001 |  |  |  |  | $ 0.0001 |  |  | $ 0.0001
Issuance of common stock |  | 5,325,000 |  |  |  |  | 83,252,520 |  |  | 82,569,168
Estimated offering expenses | $ 91,700 |  |  |  |  |  |  |  |  |
Aggregate gross proceeds |  |  |  |  |  |  | $ 0 | $ 19,266 |  |
Accumulated deficit |  |  |  |  |  |  | (557,325) |  |  | $ (497,894)
Underwriting discounts and commissions and other offering expenses |  | $ 91,700 |  |  |  |  |  |  |  |
Adicet Therapeutics [Member] |  |  |  |  |  |  |  |  |  |
Schedule Of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |
Accumulated deficit |  |  |  |  |  |  | $ 557,300 |  |  |
2021 Sales Agreement |  |  |  |  |  |  |  |  |  |
Schedule Of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |
Aggregate number of shares sold |  |  | 2,611,723 |  |  |  |  |  |  |
Sale of Stock, Price Per Share |  |  | $ 17.23 |  |  |  |  |  |  |
Sales agent commissions and expenses |  |  | $ 43,400 |  |  |  |  |  |  |
Aggregate net proceed |  |  |  |  | $ 19,300 |  |  |  |  |
Common Stock not sold |  |  |  |  |  | $ 30,000 |  |  |  |
Additional Common Stock not sold |  |  |  |  |  | 70,000 |  |  |  |
Aggregate gross proceeds |  |  |  |  |  | $ 100,000 |  |  |  |
Common Stock |  |  |  |  |  |  |  |  |  |
Schedule Of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |
Common stock price per share |  |  |  |  |  |  |  |  | $ 1 |
Issuance of common stock |  | 5,325,000 |  |  |  |  |  |  |  |
Common Stock | Jefferies LLC |  |  |  |  |  |  |  |  |  |
Schedule Of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |
Outstanding warrants, Weighted average exercise price |  | $ 2.4 |  |  |  |  |  |  |  |
Warrants outstanding |  | 8,445,333 |  |  |  |  |  |  |  |
Common stock price per share |  | $ 0.0001 |  |  |  |  |  |  |  |
Issuance of common stock |  | 27,054,667 |  |  |  |  |  |  |  |
Pre Funded Warrant | Jefferies LLC |  |  |  |  |  |  |  |  |  |
Schedule Of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |
Underwriting agreement to purchase |  |  |  |  | 30 |  |  |  |  |
Discount on underwriters warrant |  | 6.00% |  |  |  |  |  |  |  |
Purchase price per share |  | $ 2.2559 |  |  |  |  |  |  |  |
Outstanding warrants, Weighted average exercise price |  | 2.3999 |  |  |  |  |  |  |  |
Pre Funded Warrant | Jefferies LLC | Initial Public Offering |  |  |  |  |  |  |  |  |  |
Schedule Of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |
Outstanding warrants, Weighted average exercise price |  | $ 0.0001 |  |  |  |  |  |  |  |
Maximum | 2021 Sales Agreement |  |  |  |  |  |  |  |  |  |
Schedule Of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |
Aggregate gross proceeds |  |  |  | $ 75,000 |  |  |  |  |  |
Maximum | Common Stock |  |  |  |  |  |  |  |  |  |
Schedule Of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |
Common stock price per share |  |  |  |  |  |  |  |  | 1 |
Minimum | Common Stock |  |  |  |  |  |  |  |  |  |
Schedule Of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |
Common stock price per share |  |  |  |  |  |  |  |  | $ 0.0001 |

X
- Definition Additional Common Stock not sold + References No definition available. + Details
Name: | acet_AdditionalCommonStockNotSold
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Aggregate Net Proceed + References No definition available. + Details
Name: | acet_AggregateNetProceed
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Common Stock not sold + References No definition available. + Details
Name: | acet_CommonStockNotSold
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Discount On Underwriters Warrant + References No definition available. + Details
Name: | acet_DiscountOnUnderwritersWarrant
Namespace Prefix: | acet_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Sales agent commissions and expenses + References No definition available. + Details
Name: | acet_SalesAgentCommissionsAndExpenses
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Underwriting discounts and commissions and other offering expenses. + References No definition available. + Details
Name: | acet_UnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(14)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1 + Details
Name: | us-gaap_NoninterestExpenseOfferingCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of accumulated undistributed earnings (deficit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(a)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_RetainedEarningsAccumulatedDeficit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Disclose the effect on the financial statements of underwriting commitments open at year-end and subsequently settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481804/940-20-50-1 + Details
Name: | us-gaap_UnderwritingCommitments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=acet_AdicetTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=acet_SalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=acet_JefferiesLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=acet_PreFundedWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |